SYSTEMS, DEVICES, AND METHODS INCLUDING PERSONAL VAPORIZING INHALERS HAVING CARTRIDGES CONFIGURED TO HOLD MULTIPLE UNIT DOSES

• US 20160166786A1
• Filed: 12/14/2015
• Published: 06/16/2016
• Est. Priority Date: 12/16/2014
• Status: Abandoned Application

• Current Assignee: Craig E. Kinzer
• Original Assignee: Craig E. Kinzer
• Inventors: Kinzer, Craig E.
• Application Number:
  US14/968,689
• Publication Number:
  US 20160166786A1
• Time in Patent Office: Days
• CPC Class Codes: A61K 2300/00 Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00
• CPC Class Codes: A61K 31/015 carbocyclic
• CPC Class Codes: A61K 31/045 Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
• CPC Class Codes: A61K 31/352 condensed with carbocyclic rings, e.g. methantheline cannabinoids A61K31/658
• CPC Class Codes: A61K 9/0078 for inhalation via a nebulizer such as a jet nebulizer, ultrasonic nebulizer, e.g. in the form of aqueous drug solutions or dispersions
• CPC Class Codes: A61M 11/041 using heaters
• CPC Class Codes: A61M 11/042 electrical
• CPC Class Codes: A61M 15/0028 using prepacked dosages, one for each application, e.g. capsules to be perforated or broken-up
• CPC Class Codes: A61M 2205/3368 Temperature
• CPC Class Codes: A61M 2205/3553 remote, e.g. between patient's home and doctor's office
• CPC Class Codes: A61M 2205/3584 using modem, internet or bluetooth
• CPC Class Codes: A61M 2205/3592 using telemetric means, e.g. radio or optical transmission
• CPC Class Codes: A61M 2205/505 Touch-screens; Virtual keyboard or keypads; Virtual buttons; Soft keys; Mouse touches
• CPC Class Codes: A61M 2205/8206 battery-operated

Abstract

Systems, Devices, and Methods are described that enable users to manage, receive, utilize, and the like cannabis related services and products. Also described are systems, devices, and methods including an electronic vaporizer device having a cartridge assembly including one or more cartridges, each cartridge configured to hold multiple unit doses of an active agent; a cannabinoid activation component; and at least one of a terpenoid activation component or a flavonoid activation component. Also described are systems, devices, and methods for managing treatments associated with phyto-cannabinoid unit dose forms for treating various diseases or disorders.

Claims

1. An electronic vaporizer device, comprising:

a cartridge assembly including one or more cartridges, each cartridge configured to hold multiple unit doses of an active agent;

a cannabinoid activation component;

at least one of a terpenoid activation component or a flavonoid activation component; and

a communication interface component.

3. The electronic vaporizer device of claim 1, wherein the cartridge assembly includes at least one cartridge having multiple unit doses of a solid plant extract composition including at least one of a cannabinoid, a terpenoid, or a flavonoid, or combinations or mixtures thereof.

6. The electronic vaporizer device of claim 1, wherein the cartridge assembly includes at least one cartridge having multiple unit doses of a vaporizable plant extract composition including at least one of a cannabinoid, a terpenoid, or a flavonoid.

16. The electronic vaporizer device of claim 1, further comprising:

an activation chamber operably coupled to the cannabinoid activation component and the at least one of the terpenoid activation component or the flavonoid activation component.

17. The electronic vaporizer device of claim 16, wherein the cannabinoid activation component is configured to selectively heat an interior environment within the activation chamber to a temperature and for a duration sufficient to cause the release of one or more cannabinoids from a unit dose received within the activation chamber.

19. The electronic vaporizer device of claim 16, wherein the cannabinoid activation component includes circuitry including at least one heating element configured to heat an interior environment within the activation chamber to a temperature ranging from about 120°

C. to about 220°

C.

25. The electronic vaporizer device of claim 16, wherein the electronic vaporizer device includes a terpenoid activation component;

and wherein the terpenoid activation component is configured to selectively heat an interior environment within the activation chamber to a temperature and for a duration sufficient to cause the release of one or more terpenoids from a unit dose received within the activation chamber.

28. The electronic vaporizer device of claim 16, wherein the electronic vaporizer device includes a flavonoid activation component;

and wherein the terpenoid activation component is configured to selectively heat an interior environment within the activation chamber to a temperature and for a duration sufficient to cause the release of one or more flavonoids from a unit dose received within the activation chamber.

29. The electronic vaporizer device of claim 28, wherein the flavonoid activation component includes circuitry configured to activate a target flavonoid dose profile.

42. The electronic vaporizer device of claim 1, wherein the communication interface component includes circuitry configured to exchange and store cannabis experience information from one or more of a cell phone device, a computer device, a desktop computer device, a laptop computer device, a managed node device, a notebook computer device, a remote controller, a tablet device, a wearable device, or an application interface with a smart device.

2. (canceled)

4. (canceled)

5. (canceled)

7-15. -15. (canceled)

18. (canceled)

20-24. -24. (canceled)

26. (canceled)

27. (canceled)

30-41. -41. (canceled)

43-56. -56. (canceled)

57. A vaporizing inhaler device, comprising

an aerosol generation assembly including one or more active agent reservoirs forming part of a modular structure;

a vaporization chamber; and

a cannabinoid activation component operably coupled to the vaporization chamber.

58. The vaporizing inhaler device of claim 57, further comprising:

a communication interface.

59. The vaporizing inhaler device of claim 57, further comprising:

at least one of a terpenoid activation component or a flavonoid activation component.

65. The vaporizing inhaler device of claim 57, wherein the cannabinoid activation component includes one or more heating elements.

67. The vaporizing inhaler device of claim 57, wherein the modular structure includes at least one of the one agent reservoir having multiple unit doses of a vaporizable composition including at least one of a cannabinoid, a terpenoid, or a flavonoid.

73. The vaporizing inhaler device of claim 57, further comprising:

a target experience component operably coupled to the aerosol generation assembly, the target experience component operable to generate one or more control commands for formulating a target aerosol composition having a target cannabinoid content, a target terpenoid content, or a target flavonoid content.

74. The vaporizing inhaler device of claim 57, further comprising:

a target experience component operably coupled to the aerosol generation assembly, the target experience component operable to generate one or more control commands for formulating a target aerosol composition having a target unit dose based on a pain mitigation profile or a stress mitigation profile.

75. The vaporizing inhaler device of claim 57, further comprising:

a target experience component operably coupled to the aerosol generation assembly, the target experience component operable to generate one or more control commands for formulating a target aerosol composition having a target unit dose based on an auto-immune disease profile.

76. The vaporizing inhaler device of claim 57, further comprising:

a target experience component operably coupled to the aerosol generation assembly, the target experience component operable to generate one or more control commands for formulating a target aerosol composition having a target unit dose based on a target cannabinoid/terpenoid/flavonoid profile.

77. The vaporizing inhaler device of claim 57, further comprising

a target experience component operably coupled to the aerosol generation assembly, the target experience component operable to generate one or more control commands for formulating a target aerosol composition having a target unit dose based on a cannabis experience profile.

60-64. -64. (canceled)

66. (canceled)

68-72. -72. (canceled)

78-80. -80. (canceled)